Ameritas Investment Partners’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3K | Hold |
296
| – | – | ﹤0.01% | 2633 |
|
|
2025
Q4 | $16.6K | Hold |
296
| – | – | ﹤0.01% | 2723 |
|
|
2025
Q3 | $18.6K | Hold |
296
| – | – | ﹤0.01% | 2691 |
|
|
2025
Q2 | $16.8K | Hold |
296
| – | – | ﹤0.01% | 2731 |
|
|
2025
Q1 | $16.6K | Hold |
296
| – | – | ﹤0.01% | 2633 |
|
|
2024
Q4 | $18.2K | Hold |
296
| – | – | ﹤0.01% | 2676 |
|
|
2024
Q3 | $19.8K | Hold |
296
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q2 | $19.8K | Hold |
296
| – | – | ﹤0.01% | 2618 |
|
|
2024
Q1 | $21K | Hold |
296
| – | – | ﹤0.01% | 2548 |
|
|
2023
Q4 | $24.9K | Hold |
296
| – | – | ﹤0.01% | 2491 |
|
|
2023
Q3 | $25.5K | Hold |
296
| – | – | ﹤0.01% | 2428 |
|
|
2023
Q2 | $27.6K | Hold |
296
| – | – | ﹤0.01% | 2385 |
|
|
2023
Q1 | $28.1K | Hold |
296
| – | – | ﹤0.01% | 2319 |
|
|
2022
Q4 | $26.8K | Hold |
296
| – | – | ﹤0.01% | 2426 |
|
|
2022
Q3 | $25K | Hold |
296
| – | – | ﹤0.01% | 2413 |
|
|
2022
Q2 | $25K | Hold |
296
| – | – | ﹤0.01% | 2449 |
|
|
2022
Q1 | $27K | Hold |
296
| – | – | ﹤0.01% | 2427 |
|
|
2021
Q4 | $30K | Hold |
296
| – | – | ﹤0.01% | 2444 |
|
|
2021
Q3 | $27K | Hold |
296
| – | – | ﹤0.01% | 2540 |
|
|
2021
Q2 | $25K | Hold |
296
| – | – | ﹤0.01% | 2631 |
|
|
2021
Q1 | $26K | Hold |
296
| – | – | ﹤0.01% | 2453 |
|
|
2020
Q4 | $25K | Hold |
296
| – | – | ﹤0.01% | 2359 |
|
|
2020
Q3 | $24K | Hold |
296
| – | – | ﹤0.01% | 2292 |
|
|
2020
Q2 | $26K | Hold |
296
| – | – | ﹤0.01% | 2220 |
|
|
2020
Q1 | $28K | Hold |
296
| – | – | ﹤0.01% | 1992 |
|
|
2019
Q4 | $32K | Hold |
296
| – | – | ﹤0.01% | 2164 |
|
|
2019
Q3 | $28K | Hold |
296
| – | – | ﹤0.01% | 2215 |
|
|
2019
Q2 | $28K | Hold |
296
| – | – | ﹤0.01% | 2249 |
|
|
2019
Q1 | $26K | Hold |
296
| – | – | ﹤0.01% | 2255 |
|
|
2018
Q4 | $25K | Hold |
296
| – | – | ﹤0.01% | 2214 |
|
|
2018
Q3 | $28K | Hold |
296
| – | – | ﹤0.01% | 2342 |
|
|
2018
Q2 | $33K | Hold |
296
| – | – | ﹤0.01% | 2236 |
|
|
2018
Q1 | $29K | Hold |
296
| – | – | ﹤0.01% | 2232 |
|
|
2017
Q4 | $24K | Hold |
296
| – | – | ﹤0.01% | 2358 |
|
|
2017
Q3 | $21K | Hold |
296
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q2 | $21K | Hold |
296
| – | – | ﹤0.01% | 2422 |
|
|
2017
Q1 | $18K | Buy |
+296
| New | +$18.6K | ﹤0.01% | 2468 |
|
Other funds holding UTMD
BIP
VCM
MA
RHJA
Ameritas Investment Partners's UTMD Position: Q1 2026 in Review
Ameritas Investment Partners held its Utah Medical Products (UTMD) position steady in Q1 2026 at 296 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2633.
Ameritas Investment Partners first reported a position in UTMD in Q1 2017 and has held it in 37 quarters since. The position peaked at $33K in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.
- Ameritas Investment Partners held 296 shares of Utah Medical Products worth $18.3K as of Q1 2026.
- Ameritas Investment Partners left its Utah Medical Products share count unchanged in Q1 2026.
- Utah Medical Products made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2633 holding.
- Ameritas Investment Partners first reported a position in Utah Medical Products in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Utah Medical Products position peaked at $33K in Q2 2018.
- 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.